Celcuity (CELC) cautious Buy: gedatolisib upside hinges on Q2 2026 mutant cohort data in 2L HR+/HER2- breast cancer.
My name is Krista, and I would like to welcome everyone to the JetBlue Airways Fourth Quarter 2025 (sic) [ First Quarter 2026 ] Earnings Conference Call. As a reminder, today's call is being recorded.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results